Dementia Biomarker Study of Human Health Screening Patients

Dementia Biomarker Study of Human Health Screening Patients - Biomarker Study of Human Health Screening

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049044

Enrollment

2000

Registered

2022-09-29

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who agreed to participate in the dementia biomarker study at the time of their physical examination at the Center for Preventive Medicine.

Exclusion criteria

Exclusion criteria: Those who did not agree to participate in the Dementia Biomarker Study. Those who are incapable of making decisions due to dementia, etc., and are under 18 years of age.

Design outcomes

Primary

Measure	Time frame
Positive rates of plasma phosphorylated tau, plasma amyloid beta 42/40, and Neurofilament L	—

Secondary

Measure	Time frame
Changes over time with neuropsychological testing	—

Countries

Japan

Contacts

Public ContactDaisuke Ito

Keio University School of Medicine Department of Neurology/Memory center

d-ito@jk9.so-net.ne.jp03-5363-3747

Outcome results